For most people, 23andMe is synonymous with direct-to-consumer genomics. It isn’t DNA sequencing, it’s microarrays that are capable of detecting many annotated variants. As with all direct-to-consumer genomics, the cost to consumers was supposed to be subsidized by the aftermarket for genetic information. In the event, 23andMe declared bankruptcy recently, and there was a question […]

I got my genome sequenced several years ago by Veritas Genetics. They were running a special for whole genome sequencing at 30-50x coverage for $200, and for an extra $100, I got my variant call file. For a molecular geneticist, this was a dream come true! Now, anytime I see a variant reported as linked […]